Recent studies show the effectiveness of DL-alpha-difluoromethylornithine (DFMO), a drug that blocks ODC and the production of polyamines, in suppressing polyamine synthesis, thereby inhibiting cell proliferation, especially in neuroblastoma and colorectal cancer51–53. Here, ODC1 is linked to neuroblastoma.